Valens Semiconductor (VLN) Investor Day 2024 summary

Strategic vision and market positioning

• Plans to more than triple revenues by 2029, targeting $220M–$300M, with a focus on Pro AV, industrial/machine vision, automotive, and medical markets.

• Core technology enables high-bandwidth, long-reach, low-error connectivity, with 17 years of innovation, a strong patent portfolio, and over 40 million chips shipped.

• Leadership in industry standards, including HDBaseT and MIPI A-PHY, with 120 patents, hundreds of customers, and first-to-market automotive chipsets.

• Recent M&A activity, such as the acquisition of Acroname, aims to strengthen core offerings in Pro AV and industrial sectors, supporting growth.

• Focus on expanding from niche Pro AV to larger markets, leveraging unique technology advantages and a diversified customer base.

Market opportunities and product development

• Pro AV remains a foundation, with the VS6320 USB 3.0 extension chip and HDBaseT standard driving growth as video conferencing proliferates.

• Automotive segment anchored by Mercedes-Benz and Stoneridge, with new VA7000 design wins and MIPI A-PHY standardization positioning for future ADAS growth.

• Industrial and medical markets targeted with new products (VA7000, VS6320) for machine vision and single-use endoscopy, addressing rising demand for high-bandwidth, reliable connectivity.

• By 2029, total addressable markets estimated at $350M (video conferencing), $4.5B (automotive), $460M (industrial/machine vision), and $625M (single-use endoscopy, longer-term), with combined TAMs exceeding $5B.

• Emphasis on standards and ecosystem development to drive adoption and maintain leadership.

Financial performance and guidance

• 2023 revenue was $84.2M, with 2024 expected to be $57.2–$57.5M due to inventory adjustments and market softness, but recovery and growth anticipated from 2025.

• Gross margin guidance for 2024 is 58–60%, with segment margins: Pro AV (65–75%), industrial/machine vision (55–65%), automotive (35–45%).

• 2025 revenue guidance is $71–$76M, representing 25–33% growth, driven by recovery in Pro AV and new product commercialization.

• Long-term (2029) revenue goal is $220–$300M, with gross margin targets of 50–60% and adjusted EBITDA margin of 15–20%.

• M&A expected to contribute $30M–$40M to 2029 revenue, with the majority of growth organic.